Literature DB >> 20846294

Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark.

Dorte Glintborg1, Hanne Mumm, David Hougaard, Pernille Ravn, Marianne Andersen.   

Abstract

OBJECTIVE: Clinical manifestations and metabolic risk factors may differ in ethnic subgroups of patients with polycystic ovary syndrome (PCOS).
DESIGN: Retrospective trans-sectional study. PATIENTS: One thousand and two premenopausal women with the diagnoses hirsutism or PCOS were divided according to ethnicity: Caucasian (CA, n = 784), Middle East (ME, n = 190), Asian (n = 14) and others (n = 14). MEASUREMENTS: Clinical evaluation (hirsutism, BMI, waist, blood pressure), hormone analyses (testosterone, sex hormone-binding globulin, prolactin, lipids, insulin, glucose) and transvaginal ultrasound were performed. Oral glucose tolerance tests (OGTT) (n = 499) and ACTH tests (n = 434) were performed in a subgroup of patients.
RESULTS: (CA vs ME women) CA women were older [32(25-37) vs 25(18-32) years, median (quartiles)] and had increased BMI compared to ME women. After correcting for age and BMI, CA women were less hirsute, but had increased testosterone levels compared to ME women. The Rotterdam criteria were fulfilled in 56% of both populations, but PCO was diagnosed in 47% CA vs 29% ME women, P < 0·01. CA women had increased blood pressure and smoked at a higher frequency (40 vs 23%), whereas area under the curve for insulin during OGTT was decreased, all P < 0·001. Prolactin levels were significantly lower in CA women compared to ME women [7(5-10) vs 9(6-12) μg/l] and were inversely associated with smoking status.
CONCLUSION: CA women had a more adverse cardiovascular profile than ME women, whereas insulin sensitivity was higher. The prevalence of the individual Rotterdam criteria differed significantly in the two study populations.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846294     DOI: 10.1111/j.1365-2265.2010.03873.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

1.  A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome.

Authors:  Junli He; Li Wang; Junhong Liu; Feng Liu; Xuliang Li
Journal:  J Assist Reprod Genet       Date:  2012-04-21       Impact factor: 3.412

Review 2.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

3.  Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.

Authors:  L J Moran; H J Teede; M Noakes; P M Clifton; R J Norman; G A Wittert
Journal:  J Endocrinol Invest       Date:  2013-07-01       Impact factor: 4.256

4.  Screening for Androgen Excess in Women: Accuracy of Self-Reported Excess Body Hair Growth and Menstrual Dysfunction.

Authors:  Jessica L Chan; Marita Pall; Uche Ezeh; Ruchi Mathur; Margareta D Pisarska; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

5.  Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome.

Authors:  Moushira Zaki; Naglaa Hassan; Hala T El-Bassyouni; Sanaa Kamal; Walaa Basha; Osama Azmy; Khalda Amr
Journal:  Open Access Maced J Med Sci       Date:  2017-06-13

6.  Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome.

Authors:  L Afifi; L Saeed; L A Pasch; H G Huddleston; M I Cedars; L T Zane; K Shinkai
Journal:  Int J Womens Dermatol       Date:  2017-03-13

7.  Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).

Authors:  Mette B Eriksen; Michael F B Nielsen; Klaus Brusgaard; Qihua Tan; Marianne S Andersen; Dorte Glintborg; Michael Gaster
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

8.  Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.

Authors:  Jocelyne Matar Boumosleh; Scott M Grundy; Jennifer Phan; Ian J Neeland; Alice Chang; Gloria Lena Vega
Journal:  J Endocr Soc       Date:  2017-11-02

9.  The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population.

Authors:  Soha R Dargham; Lina Ahmed; Eric S Kilpatrick; Stephen L Atkin
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

10.  Comparison of metabolic syndrome elements in White and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study.

Authors:  Nikhita Chahal; Molly Quinn; Eleni A Jaswa; Chia-Ning Kao; Marcelle I Cedars; Heather G Huddleston
Journal:  F S Rep       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.